Alendronate reduces risk of vertebral and clinical fractures in women with existing vertebral fractures: Results of the fracture intervention trial.

被引：0
|
作者：
Black, DM
Cummings, SR
Thompson, D
机构：
[1] UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94143
[2] MERCK RES LABS,RAHWAY,NJ
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1996年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：P242 / P242
页数：1
相关论文
共 50 条
  • [1] Alendronate reduces the risk of vertebral and clinical fractures in women with existing vertebral fractures: Preliminary results of the Fracture Intervention Trial
    Black, DM
    Cummings, SR
    Karpf, DB
    Cauley, J
    Ensrud, K
    Genant, HK
    Haskell, W
    Marcus, R
    Nevitt, MC
    Ott, SM
    Quandt, SA
    Torner, JC
    Thompson, D
    [J]. OSTEOPOROSIS 1996, 1996, 1118 : 315 - 319
  • [2] Alendronate reduces the risk of vertebral fractures in women without pre-existing vertebral fractures: Results of the fracture intervention trial.
    Cummings, SR
    Black, DM
    Thompson, DE
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : 188 - 188
  • [3] Alendronate reduces the risk of vertebral fractures in women without pre-existing vertebral fractures: Results of the fracture intervention trial.
    Cummings, SR
    Black, DM
    Thompson, DE
    [J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 56 - 56
  • [4] Alendronate reduces the risk of vertebral and hip fractures: Final results of the fracture intervention trial.
    Hochberg, MC
    Cummings, SR
    Ensrud, KE
    Torner, JC
    Quandt, S
    Black, DM
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 582 - 582
  • [5] Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
    Black, DM
    Cummings, SR
    Karpf, DB
    Cauley, JA
    Thompson, DE
    Nevitt, MC
    Bauer, DC
    Genant, HK
    Haskell, WL
    Marcus, R
    Ott, SM
    Torner, JC
    Quandt, SA
    Reiss, TF
    Ensrud, KE
    [J]. LANCET, 1996, 348 (9041): : 1535 - 1541
  • [6] Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures - Results from the fracture intervention trial
    Cummings, SR
    Black, DM
    Thompson, DE
    Applegate, WB
    Barrett-Connor, E
    Musliner, TA
    Palermo, L
    Prineas, R
    Rubin, SM
    Scott, JC
    Vogt, T
    Wallace, R
    Yates, AJ
    LaCroix, AZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (24): : 2077 - 2082
  • [7] FRAX and Risk of Vertebral Fractures: The Fracture Intervention Trial
    Donaldson, Meghan G.
    Palermo, Lisa
    Schousboe, John T.
    Ensrud, Kristine E.
    Hochberg, Marc C.
    Cummings, Steven R.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2009, 24 (11) : 1793 - 1799
  • [8] Alendronate prevents fractures in women at very high risk: Results from the fracture intervention trial.
    Ensrud, K
    Black, D
    BarrettConnor, E
    Quandt, S
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : 155 - 155
  • [9] The efficacy of alendronate, risedronte and etidronate in treatment of osteoporosis and in reducing the risk for vertebral fractures of rheumatoid arthritis patients(fracture intervention trial.)
    Nakayama, H
    Hagiwara, F
    Tohma, S
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S498 - S498
  • [10] Alendronate reduces the risk of multiple symptomatic fractures: Results from the fracture intervention trial
    Levis, S
    Quandt, SA
    Thompson, D
    Scott, J
    Schneider, DL
    Ross, PD
    Black, D
    Suryawanshi, S
    Hochberg, M
    Yates, J
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (03) : 409 - 415
12345